2018 Medicinal Chemistry Reviews
Case History: Orkambi® (Ivacaftor/Lumacaftor), for the Treatment of Cystic Fibrosis Patients who are Homozygous for the F508del CFTR Mutation
Sabine Hadida, Fred Van Goor, Paul Negulescu, and Peter D.J. Grootenhuis
Ref. n°: REV2018-ch25
You must be connected to be able to download the pdf file of this chapter.